Octahydropyrrolo[3,4-c]pyrrole: A Diamine Scaffold for Construction of Either α4β2 or α7-Selective Nicotinic Acetylcholine Receptor (nAChR) Ligands. Substitutions that Switch Subtype Selectivity

被引:22
作者
Bunnelle, William H. [1 ]
Tietje, Karin R. [1 ]
Frost, Jennifer M. [1 ]
Peters, Dan [2 ]
Ji, Jianguo [1 ]
Li, Tao [1 ]
Scanio, Marc J. C. [1 ]
Shi, Lei [1 ]
Anderson, David J. [1 ]
Dyhring, Tino [2 ]
Gronlien, Jens H. [1 ]
Ween, Hilde [1 ]
Thorin-Hagene, Kirsten [1 ]
Meyer, Michael D. [1 ]
机构
[1] Abbott Labs, Neurosci Res, Dept R47W, Abbott Pk, IL 60064 USA
[2] NeuroSearch AS, DK-2750 Ballerup, Denmark
关键词
ANTINOCICEPTIVE PROPERTIES; COGNITIVE DEFICITS; EXTRACELLULAR DOMAIN; VENTRAL HIPPOCAMPUS; POTENTIAL TREATMENT; PARTIAL AGONIST; KNOCKOUT MICE; SUBUNIT GENE; BINDING-SITE; H-3; CYTISINE;
D O I
10.1021/jm900249k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 5-(pyridine-3-yl)octahydropyrrolo[3,4-c]pyrroles have been prepared that exhibit high affinity to alpha 4 beta 2 and/or alpha 7 nicotinic acetylcholine receptors (nAChRs). Simple substitution patterns have been identified that allow construction of ligands that are highly selective for either nAChR subtype. The effects of substitution on subtype selectivity provide some insight into the differences in the ligand binding domains of the alpha 4 beta 2 and alpha 7 receptors, especially in regions removed from the cation binding pocket.
引用
收藏
页码:4126 / 4141
页数:16
相关论文
共 75 条
[41]   Modeling multiple species of nicotine and deschloroepibatidine interacting with α4β2 nicotinic acetylcholine receptor:: From microscopic binding to phenomenological binding affinity [J].
Huang, XQ ;
Zheng, F ;
Crooks, PA ;
Dwoskin, LP ;
Zhan, CG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (41) :14401-14414
[42]   Neuronal nicotinic acetylcholine receptors: Structural revelations, target identifications, and therapeutic inspirations [J].
Jensen, AA ;
Frolund, B ;
Lijefors, T ;
Krogsgaard-Larsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :4705-4745
[43]   Selective amination of polyhalopyridines catalyzed by a palladium-xantphos complex [J].
Ji, JG ;
Li, T ;
Bunnelle, WH .
ORGANIC LETTERS, 2003, 5 (24) :4611-4614
[44]   Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists [J].
Ji, Jianguo ;
Schrimpf, Michael R. ;
Sippy, Kevin B. ;
Bunnelle, William H. ;
Li, Tao ;
Anderson, David J. ;
Faltynek, Connie ;
Surowy, Carol S. ;
Dyhring, Tino ;
Ahring, Philip K. ;
Meyer, Michael D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) :5493-5508
[45]   Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers [J].
Kitagawa, H ;
Takenouchi, T ;
Azuma, R ;
Wesnes, KA ;
Kramer, WG ;
Clody, DE ;
Burnett, AL .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (03) :542-551
[46]  
Kuntzweiler TA, 1998, DRUG DEVELOP RES, V44, P14, DOI 10.1002/(SICI)1098-2299(199805)44:1<14::AID-DDR3>3.0.CO
[47]  
2-S
[48]   Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites [J].
Le Novère, N ;
Grutter, T ;
Changeux, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3210-3215
[49]   Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia [J].
Leonard, S ;
Gault, J ;
Hopkins, J ;
Logel, J ;
Vianzon, R ;
Short, M ;
Drebing, C ;
Berger, R ;
Venn, D ;
Sirota, P ;
Zerbe, G ;
Olincy, A ;
Ross, RG ;
Adler, LE ;
Freedman, R .
ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (12) :1085-1096
[50]   Nicotinic receptors as targets for therapeutic discovery [J].
Lippiello, P. M. ;
Bencherif, M. ;
Hauser, T. A. ;
Jordan, K. G. ;
Letchworth, S. R. ;
Mazurov, A. A. .
EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (09) :1185-1203